A new CDER Office of New Drugs webinar discusses the development and use of OND Custom Medical Queries to identify potential safety signals during rev...
Harmed Americans for Reform in Medical Device Safety petitions FDA to require an IDE for the Vena MicroAngioscope and take other steps to determine if...
FDA warns South Koreas Huons Co. about CGMP violations in its manufacturing of finished drugs.
A Skadden Insights post raises the concern of FDA-regulated companies caused by the significant leadership changes at the agency.
FDA issues an early alert warning healthcare providers about a potentially high-risk device issue involving introducer kits used with Impella heart pu...
FDA warns Amazon it is marketing unapproved new drugs on its Web site.
Former FDA commissioner Scott Gottlieb supports the agency's newly announced initiative to accelerate early-stage clinical trials, arguing that the p...
FDA warns Canadas Jubilant HollisterStier General Partnership about CGMP violations in its manufacturing of finished drugs.